NNE is providing a conceptual design for refurbishment of a facility to support the transition from research to early clinical manufacturing of allogenic gene-edited cell therapies targeted towards chronic disease - in the customer’s own portfolio.
Our conceptual design provded the customer with basis for design and basis for decision. To provide a robust conceptual design, we brought in outside perspectives on cost estimate, facility concept and gene editing technology in general.
The co-creation workshop format NNE used was very engaging, practical and visual. It was clear to everybody what the intention and desired outcome was - including benchmarking with our defined business drivers.”
Fact box
Customer
Confidential
Country
USA
Technology
Gene-edited cell therapies
Format
- Co-creation with customer + contractor
- Workshop format
- Test of solution alternatives
Duration
Focused 2 week workshop
Total of 8 weeks
Project completion
2019-ongoing
Size
4,000 m2
Services provided
Conceptual design